EUVIMEDEUVIMED entdecken
Crossref

Specific loading of oncolytic VSV on CAR enhances CAR-T cell signaling and antitumor activity

Fan Xing iD, Xuemei Wang iD, Zeying Li iD, Liangying Zheng iD, Zuda Huang iD, Jieqing Guo iD, Zhihui Xi iD, Huolun Feng iD, Baijin Xia iD, Yingtong Lin iD, Fei Yu iD, Jie Chen iD und 1 weitere

Journal of Experimental Medicine · 03.11.2025 · 222 (11)

DOI: 10.1084/jem.20241851 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Experimental Medicine, online erschienen am 12.09.2025. Verfasst von Fan Xing und 12 weiteren Autor:innen. Beteiligte Einrichtung: Medical Research Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University , Guangzhou, …. Hauptthemen laut MEDLINE: Receptors, Chimeric Antigen, Oncolytic Viruses, Signal Transduction, Oncolytic Virotherapy. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guangdong Special Support Program for Young Top Talents, Southern Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oncolytic viruses (OVs) have been shown to increase the efficacy of chimeric antigen receptor (CAR) T cells in treating solid tumors. However, their combined effect has been limited by the unbalanced distribution of two agents in tumor tissue and viral infection–mediated CAR-T cell exhaustion. Here, we designed a CAR moiety by inserting the CR2 and CR3 domains (CR2/3-CAR) of low-density lipoprotein receptor, which is the viral receptor of oncolytic vesicular stomatitis virus (VSV) mutant (VSVΔ51), enabling specific loading of VSVΔ51 onto CAR-T cells. The anchored VSVΔ51 could be released from CAR-T cells and efficiently delivered to tumor tissue. Further investigation revealed that the cross-connection between viral envelope proteins and CR2/3-CAR moieties facilitated forming antigen-free CAR clusters and antigen-induced CAR synapse, triggered CAR signaling transduction, and directly pre-activated the CAR-T cells. Consequently, this approach potently enhanced the proliferation, metabolic fitness, and immunological activities of CAR-T cells, and subsequently enhanced the OV/CAR-T synergetic cytotoxicity, revealing an effective strategy for treating solid tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Chimeric AntigenOncolytic VirusesSignal TransductionOncolytic VirotherapyImmunotherapy, AdoptiveT-LymphocytesNeoplasmsVesicular stomatitis Indiana virusVesiculovirusAnimalsHumansMiceCell Line, TumorFemale

Substanzen

Receptors, Chimeric Antigen

Autor:innen und Institutionen

  • Medical Research Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University , Guangzhou, China.
  • School of Pharmaceutical Sciences, Southern Medical University , Guangzhou, China.
  • Department of Pathogen Biology and Biosecurity, Key Laboratory of Tropical Disease Control of Ministry of Education, Institute of Human Virology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.
  • Department of Gastrointestinal Surgery Department of General Surgery Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
  • Department of Medical Oncology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

ORCID-Profile: Fan Xing, Xuemei Wang, Zeying Li, Liangying Zheng, Zuda Huang, Jieqing Guo, Zhihui Xi, Huolun Feng, Baijin Xia, Yingtong Lin, Fei Yu, Jie Chen, Hui Zhang

Förderung

  • National Natural Science Foundation of China
  • Guangdong Special Support Program for Young Top Talents
  • Southern Medical University
  • The Key R&D Program of the Department of Science and Technology of Guangdong

Zitieren

APA

Xing, F., Wang, X., Li, Z., Zheng, L., Huang, Z., Guo, J., Xi, Z., Feng, H., Xia, B., Lin, Y., Yu, F., Chen, J., & Zhang, H. (2025). Specific loading of oncolytic VSV on CAR enhances CAR-T cell signaling and antitumor activity. Journal of Experimental Medicine, 222(11). https://doi.org/10.1084/jem.20241851

Vancouver

Xing F, Wang X, Li Z, Zheng L, Huang Z, Guo J, et al. Specific loading of oncolytic VSV on CAR enhances CAR-T cell signaling and antitumor activity. Journal of Experimental Medicine. 2025;222(11). doi:10.1084/jem.20241851

BibTeX
@article{Xing2025,
  author = {Xing, Fan and Wang, Xuemei and Li, Zeying and Zheng, Liangying and Huang, Zuda and Guo, Jieqing and Xi, Zhihui and Feng, Huolun and Xia, Baijin and Lin, Yingtong and Yu, Fei and Chen, Jie and Zhang, Hui},
  title = {Specific loading of oncolytic VSV on CAR enhances CAR-T cell signaling and antitumor activity},
  journal = {Journal of Experimental Medicine},
  year = {2025},
  volume = {222},
  number = {11},
  doi = {10.1084/jem.20241851}
}
Kostenlos starten →